| الوصف: |
Pieter-Paul Hekking,1 Monique van Meggelen,1 W Johan Lie,2 Rogier Arnaud Sebastiaan Hoek,3,4 Dirk van Ranst,5 Stephan Cornelis Johan van der Kleij,6 Leonard Seghers,4 Jasper Kappen,1,7 Gert-Jan Braunstahl,1,8 Johannes In ’t Veen1 On behalf of Severe Asthma & COPD Network South West Netherlands1Centre of Excellence for Asthma, COPD & Respiratory Allergy, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands; 2Department of Pulmonary Medicine, Maasstad Hospital, Rotterdam, the Netherlands; 3Department of Pulmonary Medicine, Bravis Hospital, Bergen op Zoom, the Netherlands; 4Department of Pulmonary Medicine, Erasmus MC Transplant Institute, Rotterdam, the Netherlands; 5Revant, Pulmonary Rehabilitation, Breda, the Netherlands; 6Department of Intensive Care Medicine and Home Mechanical Ventilation, Rotterdam, the Netherlands; 7Department of National Heart and Lung Institute, Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Imperial College London, London, UK; 8Department of Pulmonary Medicine, Rotterdam, the NetherlandsCorrespondence: Pieter-Paul Hekking, Franciscus Gasthuis & Vlietland, Centre of excellence for asthma, COPD & Respiratory allergy, Kleiweg, 500, Rotterdam, 3045 PM, the Netherlands, Email p.hekking@franciscus.nl |
Full Text Finder